A study analyzing the medical data of more than 133,000 people shows that those with diabetes and a medical history of non-alcoholic fatty liver disease have a significantly higher risk of cardiovascular disease and mortality. Recent data suggest that non-alcoholic fatty liver disease (NAFLD) is the most common type of liver disease affecting people in the United States. NAFLD is defined by a range of conditions determined by excess fat accumulating in the liver. Liver disease is also associated with a high risk of developing cardiovascular disease (CVD) and brings an elevated risk of mortality. At the same time, studies have shown that there is a strong association between NAFLD and type 2 diabetes. Often, when the two conditions coexist, they augment the probability of developing other complications.
However, although diabetes and NAFLD so commonly occur together, and although NAFLD is associated with a risk of CVD and death, no studies so far have conclusively shown that people with both NAFLD and diabetes are also more exposed to CVD and mortality.
But now, Prof. Sarah Wild, from the University of Edinburgh, and Prof. Christopher Byrne, from the University of Southampton - both in the United Kingdom - have analyzed data from hospital records to confirm this risk in people with NAFLD and diabetes.
They have recently presented their findings at the European Association for the Study of Diabetes Annual Meeting, held in Lisbon, Portugal.
To read the full story, visit: Medical News Today
High consumption of red and processed meat linked to non-alcoholic fatty liver disease and insulin resistance
Gastrointestinal hormone measurably improved symptoms of non-alcoholic fatty liver disease
Raising awareness about alcohol-related liver disease in women
Subscribe to the EASL newsletter